GlaxoSmithKline
GSK
$45.17
Share price
0.22%
Change (1 day)
23.65%
Change (1 year)
Categories
EPS for GlaxoSmithKline (GSK)
EPS in 2023 (TTM): $3.50
According to GlaxoSmithKline's latest financial reports the company's current EPS (TTM) is $3.50. In 2022 the company made an earnings per share (EPS) of $8.48 an increase over its 2021 EPS that were of $2.99.
EPS history for GlaxoSmithKline from 2001 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | $3.50 | -58.72% |
| 2022 | $8.48 | 183.39% |
| 2021 | $2.99 | -17.83% |
| 2020 | $3.64 | 21.82% |
| 2019 | $2.99 | 23.91% |
| 2018 | $2.41 | 141.48% |
| 2017 | $1.00 | 64.6% |
| 2016 | $0.61 | -90.64% |
| 2015 | $6.48 | 178.14% |
| 2014 | $2.33 | -48.16% |
| 2013 | $4.50 | 22.63% |
| 2012 | $3.67 | -11.32% |
| 2011 | $4.14 | 230.25% |
| 2010 | $1.25 | -70.98% |
| 2009 | $4.32 | 6.76% |
| 2008 | $4.04 | -15.14% |
| 2007 | $4.76 | 7.82% |
| 2006 | $4.42 | 19.61% |
| 2005 | $3.69 | 18.56% |
| 2004 | $3.12 | 0.36% |
| 2003 | $3.10 | 50.39% |
| 2002 | $2.06 | 31.13% |
| 2001 | $1.57 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $3.74 | 6.84% | 🇨🇭 Switzerland |
 Pfizer PFE | $1.86 | -46.87% | 🇺🇸 USA |
 Sanofi SNY | $3.18 | -9.15% | 🇫🇷 France |
 Merck MRK | $1.82 | -47.96% | 🇺🇸 USA |
 AstraZeneca AZN | $1.98 | -43.30% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | -$2.00 | -157.13% | 🇮🇱 Israel |
 Dynavax Technologies
DVAX | $0.87 | -75.15% | 🇺🇸 USA |